Early Manifest Glaucoma Trial (EMGT)
Recruitment status was Active, not recruiting
The primary purpose is to compare the effect of immediate therapy to lower the intraocular pressure (IOP) versus late or no treatment on the progression of newly detected open-angle glaucoma, as measured by increasing visual field loss and/or optic disc changes.
The secondary purposes are to determine the extent of IOP reduction attained by treatment, to explore factors that may influence glaucoma progression, and to describe the natural history of newly detected glaucoma.
Procedure: Argon Laser Trabeculoplasty
|Study Design:||Allocation: Randomized
Primary Purpose: Treatment
|Study Start Date:||October 1992|
|Department of Ophthalmology, Helsingborg Hospital|
|Department of Ophthalmology, Malmo University Hospital, University of Lund|